[A clinical evaluation of Wintomylon in the treatment of urinary infections].
D000328:Adult; D001419:Bacteria / Q000187:drug effects; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009268:Nalidixic Acid / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D009268:Nalidixic Acid